Xeltis Hemodialysis Access Graft: aXess Pivotal Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 120 participants.

Also called NCT05473299

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
  • Xeltis Registry lists this organization as the lead sponsor
Registry
  • NCT NCT05473299
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Belgium, Germany, Greece, Italy, Latvia, Poland, Portugal, Spain, United Kingdom (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05473299. Allocation not applicable; no masking; primary purpose treatment. Start 2022-11-04 (actual); primary completion 2025-06-23 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Xeltis Hemodialysis Access Graft: aXess Pivotal Study
Condition
End-stage Renal Disease
Intervention (Device)
Xeltis Hemodialysis Access (aXess) graft
Lead sponsor
Xeltis (class: industry)

Record details

Record id
cardio:ct-nct05473299
Content hash
58495f3a45ec495423b72e0723d10f391d45a0ef728903f471532f759b8dc358